NCT06337084
- Conditions
- Adnexal Diseases, Bladder Cancer, Breast Diseases, +53 more
- Locations
-
- Melbourne Theranostic Innovation Centre (MTIC) North Melbourne, Victoria, Australia
Clinical trial condition
Urothelial Carcinoma
Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.
239 public trials
74 recruiting studies
Urothelial Carcinoma trial results
NCT06617169
- Conditions
- Adnexal Diseases, Bladder Cancer, Breast Diseases, +53 more
- Locations
-
- Melbourne Theranostic Innovation Centre (MTIC) North Melbourne, Victoria, Australia
NCT05290038
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- Ospedale di Macerata, UOC Oncologia Province of Macerata, Macerata, Italy
Recruiting
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
NCT06823427
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +6 more
- Locations
-
- Hunan Tumor Hospital Changsha, Hunan, China
- Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
NCT04510129
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +63 more
- Locations
-
- Curebase San Francisco, California, United States
NCT05874921
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Disease Attributes, +21 more
- Locations
-
- Providence St. Johns Health Center Santa Monica, California, United States
- University of Florida Gainesville, Florida, United States
- Mount Sinai Medical Center of Florida, Inc. Miami, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. Tampa, Florida, United States
NCT06632262
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
- Locations
-
- Guizhou Provincial People'S Hospital Guiyang, Guizhou, China
- The Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
- The Fourth Hospital of Hebei Medical University Shijiazhuang, Heibei, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
NCT06592326
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT05229614
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +26 more
- Locations
-
- GSI Helmholtzzentrum für Schwerionenforschung GmbH Darmstadt, Germany
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
- National Center for Oncological Hadrontherapy (CNAO) Pavia, Italy
- Fondazione IRCCS Policlinico San Matteo Pavia, Italy
Recruiting
A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma
NCT05302284
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, HER2-expressing, +4 more
- Locations
-
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
- Beijing Cancer Hospital Beijing, China